Related Experiment Videos
Receptor binding studies of soft anticholinergic agents
F Huang1, P Buchwald, C E Browne
1Center for Drug Discovery, College of Pharmacy, University of Florida, Gainesville, FL 32610-0497, USA.
AAPS Pharmsci
|June 7, 2002
Summary
This study characterized soft anticholinergic agents using receptor binding assays. Potency correlated with guinea pig ileum assays, and QSAR models predicted activity for tropine-containing compounds.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Computational Chemistry
Background:
- Anticholinergic agents are widely used, but their side effects necessitate the development of safer alternatives.
- Soft anticholinergic agents are designed for targeted action and reduced systemic exposure.
- Understanding the receptor binding profiles and structure-activity relationships of these agents is crucial for drug design.
Purpose of the Study:
- To evaluate the receptor binding affinities of soft anticholinergic agents at human muscarinic receptor subtypes.
- To correlate binding affinities with functional data from guinea pig ileum assays.
- To establish quantitative structure-activity relationships (QSAR) for soft anticholinergics, particularly those containing tropine moieties.
Main Methods:
- Receptor binding studies using 4 cloned human muscarinic receptor subtypes (m1-m4).
- Measurement of pKi values for 24 soft and 5 conventional anticholinergic agents.
- Correlation analysis between pKi values and previously determined pA2 values from guinea pig ileum contraction assays.
- Quantitative structure-activity relationship (QSAR) analysis incorporating geometric, electronic, and lipophilicity descriptors.
Main Results:
- Soft anticholinergic agents exhibited pKi values ranging from 6.5 to 9.5, with most between 7.5 and 8.5.
- Strong correlations (r2 values 0.73-0.81) were found between pKi values and guinea pig ileum pA2 values across all receptor subtypes.
- QSAR models successfully characterized tropine-containing soft anticholinergics, with a linear regression model (using ovality, dipole moment, and QLogP) predicting m3 receptor affinity (r=0.88).
Conclusions:
- Soft anticholinergic agents demonstrate significant binding affinities at human muscarinic receptors.
- In vitro receptor binding data strongly correlate with in vivo functional assays, validating their predictive power.
- QSAR analysis provides valuable insights into the structural determinants of soft anticholinergic activity, guiding the design of novel agents with improved profiles.